Keywords: gsk, offers, employers, relenza, flu, vaccine, option

GSK offers employers Relenza flu vaccine option

Article | 08 September 2008

Through its US office, UK-based drug major GlaxoSmithKline has announced the launch of the Relenza (zanamivir) Inhalation Powder Pandemic Readiness ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

GlaxoSmithKline

GSK

Go to company listing

Related Drugs

Relenza

Zanamivir

Go to drug listing